- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Future Opportunities in Genitourinary Cancers
Siamak Daneshmand, MD, provides closing remarks on the management of genitourinary cancers and the future of care.
EP: 1.Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers
EP: 2.Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023
EP: 3.Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape
EP: 4.ESMO 2023 Insights: SunRISe-1 Study of TAR-200 in BCG-Unresponsive Bladder Cancer
EP: 5.Key Highlights from EV-302 Study at ESMO 2023
EP: 6.LITESPARK-003 Trial Insights: Updates from ESMO 2023
EP: 7.Future Opportunities in Genitourinary Cancers
This is a video synopsis/summary of a panel discussion involving Sia Daneshmand, MD.
Daneshmand discusses areas for improving genitourinary cancer management. Better biomarkers are needed to guide personalized therapy rather than one-size-fits-all approaches. Although genomic profiling has expanded, adequate predictive and response biomarkers are still lacking beyond select cases like FGFR3-altered bladder cancer.
Circulating tumor DNA (ctDNA) analysis is an exciting area, as seen in other cancers, to detect molecular disease and help guide adjuvant treatment decisions. Ongoing trials are evaluating ctDNA’s role in locally advanced bladder cancer.
Daneshmand briefly highlights 2 other promising European Society for Medical Oncology Congress 2023 abstracts: one on gemcitabine, cisplatin, and nivolumab in urothelial carcinoma; and TAR-210, using an intravesical formulation of erdafitinib across bladder cancer settings.
In conclusion, Daneshmand notes he is excited about the future, with these innovative trials prolonging patient survival. He sees expanded treatment options allowing patients with bladder cancer to avoid dramatic interventions like cystectomy. But continued work is needed.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
